Publications by authors named "Aaron Schultz"

Remote, digital cognitive testing on an individual's own device provides the opportunity to deploy previously understudied but promising cognitive paradigms in preclinical Alzheimer's disease (AD). The Boston Remote Assessment for NeuroCognitive Health (BRANCH) captures a personalized learning curve for the same information presented over seven consecutive days. Here, we examined BRANCH multi-day learning curves (MDLCs) in 167 cognitively unimpaired older adults (age = 74.

View Article and Find Full Text PDF

STAT5B is a vital transcription factor for lymphocytes. Here, function of two STAT5B mutations from human T cell leukemias: one substituting tyrosine 665 with phenylalanine (STAT5B ), the other with histidine (STAT5B ) was interrogated. modeling predicted divergent energetic effects on homodimerization with a range of pathogenicity.

View Article and Find Full Text PDF

Signal transduction downstream of activating stimuli controls CD8+ T cell biology, however these external inputs can become uncoupled from transcriptional regulation in Primary Immune Regulatory Disorders (PIRDs). Gain-of-function (GOF) variants in STAT3 amplify cytokine signaling and cause a severe PIRD characterized by early onset autoimmunity, lymphoproliferation, recurrent infections, and immune dysregulation. In both primary human and mouse models of STAT3 GOF, CD8+ T cells have been implicated as pathogenic drivers of autoimmunity.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the relationship between changes in β-amyloid (Aβ) levels and cognitive decline over time, highlighting that Aβ accumulation is linked to subsequent cognitive deterioration in older adults.
  • Researchers utilized sophisticated statistical models on data from a long-term study of 352 cognitively normal older participants, revealing that short-term changes in Aβ are more impactful on cognition than traditional measurements of Aβ burden and tau levels.
  • Contrary to previous findings, the study found no significant link between tau levels in the medial temporal lobe and cognitive performance, suggesting that understanding cognitive decline requires looking at dynamic changes rather than static measures.
View Article and Find Full Text PDF
Article Synopsis
  • Cognitive resilience is when people don't show mental decline even if they have signs of Alzheimer's in their brains.
  • Measuring cognitive resilience is tricky because it can't be seen directly, and one common method used might give wrong results.
  • The new method we suggest uses machine learning to improve how we measure cognitive resilience, making it more accurate and relying less on guesses about the data.
View Article and Find Full Text PDF

The strongest genetic risk factor for late-onset Alzheimer's disease (AD) is allelic variation of the APOE gene, with the following risk structure: ε4 > ε3 > ε2. The biochemical basis for this risk profile is unclear. Here, we reveal a new role for the APOE gene product, apolipoprotein E (ApoE) in regulating cellular copper homeostasis, which is perturbed in the AD brain.

View Article and Find Full Text PDF

Introduction: Sleep is crucial for memory consolidation and the clearance of toxic proteins associated with Alzheimer's disease (AD). We examined the association between sleep characteristics and imaging biomarkers of early amyloid beta (Aβ) and tau pathology as well as neurodegeneration in brain regions known to be affected in the incipient stages of AD.

Methods: Thirty-nine cognitively unimpaired (CU) participants of the Harvard Aging Brain Study underwent at-home polysomnography as well as tau positron emission tomography (flortaucipir-PET), amyloid PET (Pittsburgh compound B [PiB]-PET), and magnetic resonance imaging-derived assessment of cortical thickness (CT).

View Article and Find Full Text PDF

Background: Genetic variants that cause autosomal dominant Alzheimer's disease are highly penetrant but vary substantially regarding age at symptom onset (AAO), rates of cognitive decline, and biomarker changes. Most pathogenic variants that cause autosomal dominant Alzheimer's disease are in presenilin 1 (PSEN1), which encodes the catalytic core of γ-secretase, an enzyme complex that is crucial in production of amyloid β. We aimed to investigate whether the heterogeneity in AAO and biomarker trajectories in carriers of PSEN1 pathogenic variants could be predicted on the basis of the effects of individual PSEN1 variants on γ-secretase activity and amyloid β production.

View Article and Find Full Text PDF
Article Synopsis
  • Spatial extent (EXT) of amyloid beta (Aβ) in the neocortex may be more effective than traditional Aβ levels for early detection of Alzheimer's disease deposits and understanding their impact on cognitive decline.
  • A study using PIB-PET scans from 261 older adults found that EXT could predict cognitive decline and tau proliferation better than Aβ levels alone, revealing that Aβ spreads unevenly across regions of the brain.
  • Overall, the findings suggest that measuring Aβ spatial extent could enhance the identification of individuals at risk for Alzheimer's disease, potentially improving intervention strategies in preclinical stages.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates cognitive resilience (CR) to Alzheimer's disease (AD) in cognitively healthy older adults by analyzing imaging biomarkers and cognitive data over time using latent class mixture modeling.
  • The research involved 200 participants from the Harvard Aging Brain Study, who were categorized into three subgroups based on their cognitive trajectories: Normal, Resilient, and Declining, with the Resilient group showing higher cognitive performance and stability.
  • The findings suggest that leveraging imaging and cognitive assessments can effectively identify different levels of CR in preclinical AD stages, which could have implications for future research and interventions.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines how changes in everyday functioning, particularly through a phone task, relate to tau and amyloid levels in cognitively healthy older adults.
  • Seventy-six participants were assessed over approximately two years, using tasks that simulated real-life activities like refilling prescriptions and selecting doctors.
  • The results found that higher levels of baseline amyloid and tau were linked to a faster decline in performance on one specific task (APT-PCP), suggesting early indicators of cognitive decline can be detected through these assessments.
View Article and Find Full Text PDF

Background: Autopsy work indicates that the widely-projecting noradrenergic pontine locus coeruleus (LC) is among the earliest regions to accumulate hyperphosphorylated tau, a neuropathological Alzheimer's disease (AD) hallmark. This early tau deposition is accompanied by a reduced density of LC projections and a reduction of norepinephrine's neuroprotective effects, potentially compromising the neuronal integrity of LC's cortical targets. Previous studies suggest that lower magnetic resonance imaging (MRI)-derived LC integrity may signal cortical tissue degeneration in cognitively healthy, older individuals.

View Article and Find Full Text PDF

Importance: Studies have suggested that maternal history of late-onset Alzheimer disease, but not paternal, predisposes individuals to higher brain β-amyloid (Aβ) burden, reduced brain metabolism, and lower gray matter volumes.

Objective: To characterize maternal vs paternal history of memory impairment in terms of brain Aβ-positron emission tomography (Aβ-PET) and baseline cognition among a large sample of cognitively unimpaired older adults.

Design, Setting, And Participants: This cross-sectional study leveraged data from 4413 individuals who were screened for the Anti-Amyloid Treatment in Asymptomatic Alzheimer (A4) study, a randomized clinical trial conducted across 67 sites in the US, Australia, Canada, and Japan aimed at Alzheimer disease prevention.

View Article and Find Full Text PDF

Background: Autopsy work reported that neuronal density in the locus coeruleus (LC) provides neural reserve against cognitive decline in dementia. Recent neuroimaging and pharmacological studies reported that left frontoparietal network functional connectivity (LFPN-FC) confers resilience against beta-amyloid (Aβ)-related cognitive decline in preclinical sporadic and autosomal dominant Alzheimer's disease (AD), as well as against LC-related cognitive changes. Given that the LFPN and the LC play important roles in attention, and attention deficits have been observed early in the disease process, we examined whether LFPN-FC and LC structural health attenuate attentional decline in the context of AD pathology.

View Article and Find Full Text PDF

Introduction: Animal research has shown that tau pathology in the locus coeruleus (LC) is associated with reduced norepinephrine signaling, lower projection density to the medial temporal lobe (MTL), atrophy, and cognitive impairment. We investigated the contribution of LC-MTL functional connectivity (FC) on cortical atrophy across Braak stage regions and its impact on cognition.

Methods: We analyzed functional magnetic resonance imaging and amyloid beta (Aβ) positron emission tomography data from 128 cognitively normal participants, associating novelty-related FC with longitudinal atrophy and cognition with and without Aβ moderation.

View Article and Find Full Text PDF

In addition to amyloid and tau pathology, elevated systemic vascular risk, white matter injury, and reduced cerebral blood flow contribute to late-life cognitive decline. Given the strong collinearity among these parameters, we proposed a framework to extract the independent latent features underlying cognitive decline using the Harvard Aging Brain Study (N = 166 cognitively unimpaired older adults at baseline). We used the following measures from the baseline visit: cortical amyloid, inferior temporal cortex tau, relative cerebral blood flow, white matter hyperintensities, peak width of skeletonized mean diffusivity, and Framingham Heart Study cardiovascular disease risk.

View Article and Find Full Text PDF
Article Synopsis
  • Wildlife is facing increased risks from cancer-causing substances, which affects their behavior and population dynamics.
  • The study examined the effects of cadmium, a carcinogen, on wild planaria's activity over a 14-day period, divided into exposure and recovery phases.
  • Results showed that cadmium-exposed planaria were less active but eventually returned to pre-exposure activity levels, indicating that cancer risk factors can change behavioral patterns and highlight the need for advanced research in behavioral ecology.
View Article and Find Full Text PDF

Vascular dysfunction is increasingly recognized as an important contributor to the pathogenesis of Alzheimer's disease. Alterations in vascular endothelial growth factor (VEGF) pathways have been implicated as potential mechanisms. However, the specific impact of VEGF proteins in preclinical Alzheimer's disease and their relationships with other Alzheimer's disease and vascular pathologies during this critical early period remain to be elucidated.

View Article and Find Full Text PDF

Biological models with genetic similarities to humans are used for exploratory research to develop behavioral screening tools and understand sensory-motor interactions. Their small, often mm-sized appearance raises challenges in the straightforward quantification of their subtle behavioral responses and calls for new, customisable research tools. 3D printing provides an attractive approach for the manufacture of custom designs at low cost; however, challenges remain in the integration of functional materials like porous membranes.

View Article and Find Full Text PDF

The presence of doubly uniparental inheritance (DUI) in bivalves represents a unique mode of mitochondrial transmission, whereby paternal (male-transmitted M-type) and maternal (female-transmitted F-type) haplotypes are transmitted to offspring separately. Male embryos retain both haplotypes, but the M-type is selectively removed from females. Due to the presence of heteroplasmy in males, mtDNA can recombine resulting in a 'masculinized' haplotype referred to as M-type.

View Article and Find Full Text PDF

Many of the Alzheimer's disease (AD) risk genes are specifically expressed in microglia and astrocytes, but how and when the genetic risk localizing to these cell types contributes to AD pathophysiology remains unclear. Here, we derive cell-type-specific AD polygenic risk scores (ADPRS) from two extensively characterized datasets and uncover the impact of cell-type-specific genetic risk on AD endophenotypes. In an autopsy dataset spanning all stages of AD (n = 1457), the astrocytic ADPRS affected diffuse and neuritic plaques (amyloid-β), while microglial ADPRS affected neuritic plaques, microglial activation, neurofibrillary tangles (tau), and cognitive decline.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the relationship between hippocampal volume (HV) atrophy, β-amyloid (Aβ), tau, and cognitive decline in older adults without dementia.
  • Faster HV atrophy was found to correlate with quicker cognitive decline, accounting for 10% of the variance in cognitive impairment beyond Aβ and tau measures.
  • Overall, combining data from various imaging biomarkers explained 45% of the variance in cognitive decline over a 10-year period.
View Article and Find Full Text PDF

Importance: Increased white matter hyperintensity (WMH) volume is a common magnetic resonance imaging (MRI) finding in both autosomal dominant Alzheimer disease (ADAD) and late-onset Alzheimer disease (LOAD), but it remains unclear whether increased WMH along the AD continuum is reflective of AD-intrinsic processes or secondary to elevated systemic vascular risk factors.

Objective: To estimate the associations of neurodegeneration and parenchymal and vessel amyloidosis with WMH accumulation and investigate whether systemic vascular risk is associated with WMH beyond these AD-intrinsic processes.

Design, Setting, And Participants: This cohort study used data from 3 longitudinal cohort studies conducted in tertiary and community-based medical centers-the Dominantly Inherited Alzheimer Network (DIAN; February 2010 to March 2020), the Alzheimer's Disease Neuroimaging Initiative (ADNI; July 2007 to September 2021), and the Harvard Aging Brain Study (HABS; September 2010 to December 2019).

View Article and Find Full Text PDF

Clinically normal females exhibit higher F-flortaucipir (FTP)-PET signal than males across the cortex. However, these sex differences may be explained by neuroimaging idiosyncrasies such as off-target extracerebral tracer retention or partial volume effects (PVEs). 343 clinically normal participants (female = 58%; mean[SD]=73.

View Article and Find Full Text PDF

The performance of individual reverse osmosis (RO) systems varies significantly with different contaminants of emerging concern (CECs). As such, log reduction values (LRVs) of the concentration of these chemicals cannot be arbitrarily credited in water treatment and water recycling. This study looks to present an approach to the management of chemical risks by providing a systematic validation of RO barrier performance with respect to LRV credits for various classes of CECs.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Aaron Schultz"

  • - Aaron Schultz's recent research primarily focuses on understanding the biological and cognitive correlates of Alzheimer's disease, particularly through the use of neuroimaging techniques to explore relationships between amyloid and tau pathology, cognitive decline, and factors influencing cognitive resilience.
  • - His studies employ advanced statistical modeling and machine learning techniques to operationalize constructs like cognitive resilience and investigate the impact of genetic factors (such as APOE genotype) on neurobiological processes like copper regulation and amyloid production.
  • - Schultz's findings contribute to identifying early biomarkers and characteristics associated with increased risk of cognitive decline, such as sleep patterns and familial history of memory impairment, thereby enhancing the potential for early intervention in Alzheimer's disease.